For the readers interested in the stock health of Cellect Biotechnology Ltd. (APOP). It is currently valued at $5.87. When the transactions were called off in the previous session, Stock hit the highs of $6.5899, after setting-off with the price of $6.33. Company’s stock value dipped to $5.86 during the trading on the day. When the trading was stopped its value was $6.47.Recently in News on September 2, 2021, Cellect Biotechnology Announces the ApoGraft™ Bone Marrow Transplantation of First Patient in U.S.. Recruitment of Patient Provides Momentum to Commence Funding for the Technology under US Entity EnCellX. You can read further details here
Cellect Biotechnology Ltd. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $8.88 on 09/03/21, with the lowest value was $2.10 for the same time period, recorded on 04/20/21.
Cellect Biotechnology Ltd. (APOP) full year performance was 183.57%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Cellect Biotechnology Ltd. shares are logging -33.90% during the 52-week period from high price, and 255.87% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.65 and $8.88.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 715258 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Cellect Biotechnology Ltd. (APOP) recorded performance in the market was 171.76%, having the revenues showcasing 93.09% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 22.95M, as it employees total of 12 workers.
Analysts verdict on Cellect Biotechnology Ltd. (APOP)
During the last month, 0 analysts gave the Cellect Biotechnology Ltd. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 3.76, with a change in the price was noted +3.52. In a similar fashion, Cellect Biotechnology Ltd. posted a movement of +149.79% for the period of last 100 days, recording 2,225,713 in trading volumes.
Cellect Biotechnology Ltd. (APOP): Technical Analysis
Raw Stochastic average of Cellect Biotechnology Ltd. in the period of last 50 days is set at 46.35%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 39.44%. In the last 20 days, the company’s Stochastic %K was 47.08% and its Stochastic %D was recorded 48.12%.
Let’s take a glance in the erstwhile performances of Cellect Biotechnology Ltd., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 171.76%. Additionally, trading for the stock in the period of the last six months notably improved by 65.35%, alongside a boost of 183.57% for the period of the last 12 months. The shares increased approximately by -1.01% in the 7-day charts and went down by 50.51% in the period of the last 30 days. Common stock shares were driven by 93.09% during last recorded quarter.